Patient Buzz | Skin Signs of Breast Cancer
Breast cancer is the most common cancer in women other than skin cancer. Current estimates show one in eight women will develop invasive breast cancer during their lifetime. That means in an average dermatology clinic day, it’s quite likely to encounter a patient who has experienced breast cancer. As noted in an ABC News article, signs of breast cancer can appear on the skin and breast cancer th …
Breast cancer is the most common cancer in women other than skin cancer. Current estimates show one in eight women will develop invasive breast cancer during their lifetime. That means in an average dermatology clinic day, it’s quite likely to encounter a patient who has experienced breast cancer. As noted in an ABC News article, signs of breast cancer can appear on the skin and breast cancer th … Continue reading "Patient Buzz | Skin Signs of Breast Cancer"
In an insightful session at the ODAC Dermatology Conference, leading vitiligo expert Dr. Iltefat Hamzavi—clinical associate professor of dermatology at Wayne State University and senior staff dermatologist at Henry Ford Hospital—shared key strategies for tackling this complex condition. Here is a practical summary of his top clinical pearls, from disease stabilization to emerging systemic trea … 
Atopic dermatitis (AD) is a distressing condition, with intense itch and pain, disrupted sleep, and multifaceted therapeutic protocols. For patients with skin of color, achieving clear or almost clear skin can feel like an especially challenging goal. Post-inflammatory hyperpigmentation (PIH) can mask as active AD, compounding the psychosocial impact of the condition and complicating treatment. A … 
Which of the following is TRUE regarding this condition?
A. 50% of patients will eventually develop systemic involvement
B. C3 deficiency increases susceptibility to this condition
C. Biopsy typically shows a thinned basement membrane
D. Squamous cell carcinoma is a potential sequela
E. UV exposure is helpful in treatment
To find out the correct answer and read the explanation, … 
It’s an exciting era for topicals in atopic dermatitis with several non-steroidal treatment options, including aryl hydrocarbon receptor agonists. In an interview with Next Steps in Derm, in partnership with Skin of Color Update and with support from Organon, Mona Shahriari, MD, FAAD, shares how tapinarof, an aryl hydrocarbon receptor agonist, addresses the two pillars of atopic dermatitis mana …